|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||||
| Amortization of debt discount and debt issuance cost | |||||
| Depreciation and amortization | |||||
| Stock based compensation | |||||
| Stock issued for modification of notes payable | |||||
| Stock issued for services | |||||
| Foreign currency transaction (gain) loss | |||||
| Remeasurement gain on translation of foreign subsidiary | |||||
| Non cash implied interest | |||||
| Bad debts | |||||
| Bad debt, related party | |||||
| Gain on settlement of debt | |||||
| Write-off of inventory | |||||
| Stock issued for loan financing | |||||
| Income from employee retention credits | |||||
| Income from insurance on stolen goods | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other receivables | |||||
| Loan receivable, related party | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Prepaid expense, related party | |||||
| Income taxes payable | |||||
| Contract liabilities | |||||
| Accounts payable and accrued liabilities | |||||
| Accounts payable, related party | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Financing Activities | |||||
| Advances from related party | |||||
| Repayments of advances to related party | |||||
| Repayment of notes payable, related party | |||||
| Proceeds from notes payable | |||||
| Payment of loan financing fees | |||||
| Net cash provided by financing activities | |||||
| Cash and Cash Equivalents, beginning of year | |||||
| Cash and Cash Equivalents, end of year | |||||
| Effect of exchange rate on cash, cash equivalents and restricted cash | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, Cash Equivalents and restricted cash, beginning of year | |||||
| Cash, Cash Equivalents and restricted cash, end of year | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Number of common stock issued | |||||
| Income taxes | |||||
| Supplemental Disclosure of Non-cash Investing and Financing Activities: | |||||
| Accounts payable converted to loan payable upon settlement | |||||
| Reduction of short term related party note payable by reduction of prepaid balance | |||||
| Issuance of common stock for loan financing | |||||
| Issuance of pre-funded warrants for settlement of shareholder notes payable | |||||
| Exercise of pre-funded warrants | |||||
| Loan fees payable to lender | |||||
Loading...